T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
MSC Industrial Direct
MSM
$6.78B
| $1.41M | ﹤0.01% |
18,816
+477
| +3% | +$39.1K |
|
1727
iShares S&P Small-Cap 600 Value ETF
IJS
$8.45B
| $1.41M | ﹤0.01% |
15,835
+1,679
| +12% | +$161K |
|
1728
Resideo Technologies
REZI
$3.11B
| $1.41M | ﹤0.01% |
72,390
+3,813
| +6% | +$86.1K |
|
|
TMHC
1729
DELISTED
Taylor Morrison
TMHC
| $1.4M | ﹤0.01% |
60,105
+974
| +2% | +$25.8K |
|
1730
Qiagen
QGEN
$8.96B
| $1.4M | ﹤0.01% |
27,891
+4,569
| +20% | +$223K |
|
1731
Simmons First National
SFNC
$3.47B
| $1.4M | ﹤0.01% |
65,619
+2,024
| +3% | +$49.1K |
|
1732
Grand Canyon Education
LOPE
$3.76B
| $1.38M | ﹤0.01% |
14,698
-149
| -1% | -$13.9K |
|
1733
Jack in the Box
JACK
$337M
| $1.38M | ﹤0.01% |
24,604
-15,635
| -39% | -$1.19M |
|
1734
Upstart Holdings
UPST
$3.02B
| $1.38M | ﹤0.01% |
43,606
+7,362
| +20% | +$438K |
|
1735
Celsius Holdings
CELH
$7.35B
| $1.38M | ﹤0.01% |
63,312
+3,066
| +5% | +$59.1K |
|
1736
Renasant Corp
RNST
$4.02B
| $1.37M | ﹤0.01% |
47,696
+404
| +0.9% | +$12.4K |
|
1737
Herbalife
HLF
$1.28B
| $1.37M | ﹤0.01% |
67,032
+14,514
| +28% | +$359K |
|
1738
Community Bank
CBU
$3.48B
| $1.37M | ﹤0.01% |
21,622
+275
| +1% | +$18K |
|
1739
WaFd
WAFD
$2.82B
| $1.36M | ﹤0.01% |
45,395
-10,365
| -19% | -$325K |
|
1740
Stepan Co
SCL
$1.48B
| $1.36M | ﹤0.01% |
13,439
+613
| +5% | +$63.4K |
|
|
CNH
1741
CNH Industrial
CNH
$16.7B
| $1.36M | ﹤0.01% |
118,227
+4,600
| +4% | +$65.5K |
|
1742
TriNet
TNET
$3.18B
| $1.36M | ﹤0.01% |
17,534
+4,721
| +37% | +$394K |
|
1743
Four Corners Property Trust
FCPT
$2.77B
| $1.36M | ﹤0.01% |
51,049
+4,268
| +9% | +$116K |
|
|
CPE
1744
DELISTED
Callon Petroleum Company
CPE
| $1.35M | ﹤0.01% |
34,558
+441
| +1% | +$23.6K |
|
1745
iShares MSCI EAFE Growth ETF
EFG
$17.4B
| $1.35M | ﹤0.01% |
16,802
| – | – |
|
1746
Signet Jewelers
SIG
$3.54B
| $1.35M | ﹤0.01% |
25,233
+217
| +0.9% | +$14.2K |
|
1747
Medifast
MED
$128M
| $1.34M | ﹤0.01% |
7,410
-1,676
| -18% | -$300K |
|
1748
Park Hotels & Resorts
PK
$3.06B
| $1.33M | ﹤0.01% |
98,228
-9,110
| -8% | -$161K |
|
1749
RLI Corp
RLI
$5.86B
| $1.33M | ﹤0.01% |
22,854
+320
| +1% | +$18.3K |
|
1750
Fulton Financial
FULT
$4.72B
| $1.33M | ﹤0.01% |
91,964
-12,011
| -12% | -$186K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.